The observation of overexpression of CACNA1A, CACNA1C, and CACNA1D could make them likely targets in cancer treatment, as it suggests that blockage or partial inhibition of their expression could help to modulate the status of metastatic diseases. Here, CACNA1D is linked to cancer.